OPKO Health to Participate in Two Upcoming Investment Conferences
August 30, 2021 09:04 ET
|
OPKO Health, Inc.
MIAMI, Aug. 30, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in two upcoming virtual investor conferences. 14th Annual Barrington...
OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results
July 29, 2021 16:05 ET
|
OPKO Health, Inc.
MIAMI, July 29, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended June 30, 2021. Business Highlights ...
OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
July 20, 2021 08:00 ET
|
OPKO Health, Inc.
MIAMI, July 20, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended June 30, 2021, as well as discuss financial...
OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics
July 12, 2021 08:00 ET
|
OPKO Health, Inc.
MIAMI, July 12, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced it has entered into an exclusive worldwide agreement with privately held CAMP4 Therapeutics Corporation...
OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference
July 08, 2021 16:05 ET
|
OPKO Health, Inc.
MIAMI, July 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Ladenburg Thalmann Healthcare Conference being held virtually...
OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx
June 22, 2021 08:00 ET
|
OPKO Health, Inc.
MIAMI, June 22, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Katherine Stueland as President and Chief Executive Officer of GeneDx, Inc., the global...
OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics
June 21, 2021 08:03 ET
|
OPKO Health, Inc.
MIAMI, June 21, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its subsidiary EirGen Pharma has entered into an agreement with Nicoya Macau Limited, an affiliate of...
OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland
June 17, 2021 07:00 ET
|
OPKO Health, Inc.
MIAMI, June 17, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in...
OPKO Health to Participate in the Jefferies Virtual Healthcare Conference
May 27, 2021 08:30 ET
|
OPKO Health, Inc.
MIAMI, May 27, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 1-4,...
OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor
May 24, 2021 07:30 ET
|
OPKO Health, Inc.
MIAMI, May 24, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE® in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius...